Skip to content
Screener

Black Diamond Therapeutics, Inc. BDTX Q1 2026 earnings

Reported May 7, 2026 · After market close

EPS-$0.16Beat by $0.02
Revenue estimate$25.0M
EPS estimate-$0.18

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$8.3M
EPS estimate-$0.06

FAQ

When did Black Diamond Therapeutics, Inc. report Q1 2026 earnings?
Black Diamond Therapeutics, Inc. (BDTX) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Black Diamond Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Black Diamond Therapeutics, Inc. reported eps of $-0.16 for Q1 2026.
Did Black Diamond Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.18 by $0.02.
Where can I find Black Diamond Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001701541-26-000015) and the 10-Q periodic report (0001701541-26-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.